4
Changes in Ownership
MAXCYTE, INC. Filed Acc 0001209191-23-047756
Director sold 5,000 shares at $3.70 ($18,500)
- Director acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Johnston John Joseph Director | 2023-08-28 | Option exercise 10b5-1 | +100 | $1.64 | $164 | 120,683 | D |
| Johnston John Joseph Director | 2023-08-28 | Sale 10b5-1 | −100 | $3.70 | $370 | 120,583 | D |
| Johnston John Joseph Director | 2023-08-29 | Option exercise 10b5-1 | +2,059 | $1.64 | $3,379 | 122,642 | D |
| Johnston John Joseph Director | 2023-08-29 | Sale 10b5-1 | −2,059 | $3.70 | $7,618 | 120,583 | D |
| Johnston John Joseph Director | 2023-08-30 | Option exercise 10b5-1 | +2,841 | $1.64 | $4,662 | 123,424 | D |
| Johnston John Joseph Director | 2023-08-30 | Sale 10b5-1 | −2,841 | $3.70 | $10,512 | 120,583 | D |
| Derivatives | |||||||
| Johnston John Joseph Director | 2023-08-28 | Option exercise · Stock Option (right to buy) 10b5-1 | −100 | 13,617 | D | ||
| Johnston John Joseph Director | 2023-08-29 | Option exercise · Stock Option (right to buy) 10b5-1 | −2,059 | 11,558 | D | ||
| Johnston John Joseph Director | 2023-08-30 | Option exercise · Stock Option (right to buy) 10b5-1 | −2,841 | 8,717 | D | ||
| Open-market sales · 5,000 sh · avg $3.70 · $18,500 | |||||||
Loading xslF345X05/doc4.xml…